Details for New Drug Application (NDA): 016515
✉ Email this page to a colleague
NDA 016515 describes SODIUM IODIDE I 131, which is a drug marketed by CIS, Curium, Jubilant, and Intl Isotopes, and is included in six NDAs. It is available from two suppliers. Additional details are available on the SODIUM IODIDE I 131 profile page.
The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
Summary for 016515
| Tradename: | SODIUM IODIDE I 131 |
| Applicant: | Curium |
| Ingredient: | sodium iodide i-131 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 3.5-150mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.8-100mCi | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
